|
|
 |
 | Medical News Releases > News Topics > Medical Science >
Cancer
The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is an international leader in patient care, cancer research, prevention, education and community outreach and a National Cancer Institute-designated Cancer Center.
Learn more about the advances in cancer research through the news stories and experts listed below.
| Faculty Experts: |
Showing Cancer Experts 1 through 5 of 19.
- Show More |
|
Graham Colditz
Associate Director, Prevention and Control, Siteman Cancer Center
 |
| Colditz |
Dr. Colditz is an Epidemiologist and Associate Director for Prevention and Control at the Alvin J. Siteman Cancer Center, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri. He is the Niess-Gain Family Professor in Medicine, Department of Surgery, at Washington ...
Media assistance: (314) 286-0141 / ericsong@wustl.edu
|
Dione Farria
Assistant Professor of Radiology
Dione Farria is Co-Director for the Alvin J. Siteman Cancer Center Program for the Elimination of Cancer Disparities (PECaD) and an assistant professor of Radiology, Division of Diagnostic Radiology, Section of Breast Imaging. She is certified by the American Board of Radiology and American Board of ...
Expertise: Breast imaging, breast cancer, doctor-patient communication
Media assistance: (314) 286-0141 / ericsong@wustl.edu
|
David Gutmann, M.D., Ph.D.
Donald O. Schnuck Family Professor of Neurology
Gutmann is the founder and director of the Neurofibromatosis Clinical Program, which is dedicated to treating the common inherited tumor predisposition syndrome, neurofibromatosis (NF). Individuals with NF have an increased risk of developing brain tumors and other cancers. As national leader in the ...
Expertise: Brain tumors, cancer genetics, neurofibromatosis, molecular genetics, neurosciences, neurology
Media assistance: (314) 286-0122 / purdym@wustl.edu
|
Michael DeBaun
Professor of Pediatrics, Biostatistics and Neurology
Dr. DeBaun is a professor of pediatrics, biostatistics and neurology and directs the Sickle Cell Medical Treatment and Education Center at St. Louis Children's Hospital. He is board-certified in pediatrics and pediatric hematology/oncology. He received a MPH in epidemiology from The Johns Hopkins University ...
Expertise: overgrowth cancer predisposition syndromes, public health issues, sickle cell disease
Media assistance: (314) 286-0120 / westerhousej@wustl.edu
|
John DiPersio
Chief of the Division of Bone Marrow Transplantation and Stem Cell Biology
DiPersio helped pioneer stem cell transplants and now focuses his research efforts on improving the success of bone marrow and stem cell transplants for the treatment of cancer and disorders of the blood. He is investigating the use of gene therapy to control graft versus host disease that is a main ...
Expertise: bone marrow transplantation, leukemia/lymphoma, stem cell transplantation, graft vs. host disease
Media assistance: (314) 286-0141 / ericsong@wustl.edu
|
Showing Cancer Experts 1 through 5 of 19.
- Show More |
|
| News Stories & Tip Sheets: |
Showing Cancer Stories 1 through 3 of 180.
- Show More |
|
Turning the heat up on tumors
Researchers find way to make tumor cells easier to destroy
May 6,
2008 -- Tumors have a unique vulnerability that can be exploited to make them more sensitive to heat and radiation, researchers at the School of Medicine report. The University radiation oncology researchers found that tumors have a built-in mechanism that protects them from heat (hyperthermia) damage and most likely decreases the benefit of hyperthermia and radiation as a combined therapy.
|
Big things from small packages
Nano-sized technology has super-sized effect on tumors
April 2,
2008 --
 |
| Nanoparticles (yellow) show that a treated tumor (left) has less blood vessel growth than an untreated tumor. |
Anyone facing chemotherapy would welcome an advance promising to dramatically reduce their dose of these often harsh drugs. Using nanotechnology, researchers at the School of Medicine have taken a step closer to that goal. The researchers focused a powerful drug directly on tumors in rabbits using drug-coated nanoparticles.
|
A change of plans
Study confirms impact of PET scans on cancer care
March 26,
2008 -- A national review has revealed that positron emission tomography (PET) scans of cancer patients led clinicians to change treatment plans for more than a third of the patients, scientists report this week in the Journal of Clinical Oncology.
|
Showing Cancer Stories 1 through 3 of 180.
- Show More |
|
Genetic Link Tied to Smoking Addiction
Associated Press
and 256 others
April 3,
2008 -- The discovery by three separate teams of scientists makes the strongest case so far for the biological underpinnings of nicotine addiction and sheds more light on how genetics and lifestyle habits join forces to cause cancer.
This finding could someday lead to screening tests and customized treatments for smokers trying to kick the habit.
"This is really telling us that the vulnerability to smoking and how much you smoke is clearly biologically based," said WUSTL psychiatry professor Laura Bierut, a genetics and smoking expert who did not take part in the studies. She praised the research as "very intriguing."
|
McCain works to answer age and health questions
Boston Globe
and 5 others
March 27,
2008 -- David Carr, clinical director of WUSTL's division of geriatrics and nutritional science, said the fact that McCain has gone five years without a melanoma recurrence is good news.
|
Stress Can Help Trigger Stroke
The Washington Post
and 8 others
March 4,
2008 -- The notion that stress can help bring on a stroke may have merit, British researchers say.
WUSTL neurology professor Mark Goldberg comments.
|
Women who undergo breast reconstruction after cancer surgery are twice as likely to develop an infection
The Times (London)
Jan. 29,
2008 -- News item on WUSTL medical research -- Women who undergo breast reconstruction after cancer surgery are twice as likely to develop an infection at the surgical site if they are given a prosthetic implant instead of their own tissue.
The study appeared in the January issue of Archives of Surgery.
|
Study Says Implants Double Risk of Infection After Breast Reconstructive Surgery
The New York Times
and 27 others
Jan. 22,
2008 -- More than one in 20 patients undergoing breast surgery later developed infections at incision sites, according to a new study, a complication that was more common than thought. Study co-authors WUSTL infectious diseases professor Margaret Olsen and WUSTL plastic and reconstructive surgery professor Keith Brandt comment.
|
Affiliated with Barnes-Jewish Hospital and St. Louis Children's Hospital, members of BJC HealthCare.
Please contact us and let us know how we can assist you.
Technical problems with this Web site? Email questions or comments.
Please review the WUSTL News & Information copyright/privacy policy.
| |
|
| | |
|
Download
Show More Cancer Clips
Email this page
Print ready page